1Cell.Ai Inc.

1Cell.Ai Inc. company information, Employees & Contact Information

Updated May 2026

Quick answer

1Cell.Ai Inc. is a Biotechnology Research company and founded in 2021. It has approximately 167 employees on record. Contact data was last refreshed in May 2026. Find 1Cell.Ai Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

1Cell.Ai Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies. 1Cell.Ai Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.

Company Details

Employees
167
Founded
-
Address
209, B Wing, Go Square,, Aundh-Hinjewadi Road,wakad,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
IT Consulting.
HQ
Pune , Maharashtra
Looking for a particular 1Cell.Ai Inc. employee's phone or email?

1cell.ai Inc. Questions

News

1Cell.Ai, Formerly OneCell Diagnostics, Launches OncoIncytes Integrating Multi-Modal Data for Precision Oncology - PR Newswire

1Cell.Ai, Formerly OneCell Diagnostics, Launches OncoIncytes Integrating Multi-Modal Data for Precision Oncology PR Newswire

Seeing What Can’t Be Seen - Inside Precision Medicine

Seeing What Can’t Be Seen Inside Precision Medicine

From data to therapy: emerging tech driving cancer drug discovery - Drug Target Review

From data to therapy: emerging tech driving cancer drug discovery Drug Target Review

AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion - PR Newswire

AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion PR Newswire

Rx Rundown: Sanofi, Regeneron, Havas and more - Medical Marketing and Media

Rx Rundown: Sanofi, Regeneron, Havas and more Medical Marketing and Media

As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’ - BioSpace

As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’ BioSpace

AI and the future of genomics - TechTarget

AI and the future of genomics TechTarget

New smartphone battery platform targets AI workloads with high discharge capability - EE World Online

New smartphone battery platform targets AI workloads with high discharge capability EE World Online

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments - Business Wire

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments Business Wire

Rett syndrome discovery could lead to better treatments - Drug Target Review

Rett syndrome discovery could lead to better treatments Drug Target Review

Novartis licenses innovative treatment for Huntington’s disease - Drug Target Review

Novartis licenses innovative treatment for Huntington’s disease Drug Target Review

E. coli alters ribosomes to survive antibiotic treatment - Drug Target Review

E. coli alters ribosomes to survive antibiotic treatment Drug Target Review

Multi-omic approach classifies biomarkers for paediatric sepsis - Drug Target Review

Multi-omic approach classifies biomarkers for paediatric sepsis Drug Target Review

Researchers discover compound that could treat Chagas disease - Drug Target Review

Researchers discover compound that could treat Chagas disease Drug Target Review

Lung fibrosis in mice successfully reversed by scientists - Drug Target Review

Lung fibrosis in mice successfully reversed by scientists Drug Target Review

Synthetic antibodies show efficacy against bunyaviruses, study finds - Drug Target Review

Synthetic antibodies show efficacy against bunyaviruses, study finds Drug Target Review

New strategy developed to speed up drug discovery process - Drug Target Review

New strategy developed to speed up drug discovery process Drug Target Review

Protein sequencing method could transform biological research - Drug Target Review

Protein sequencing method could transform biological research Drug Target Review

Short peptides discovery could lead to new treatments for Alzheimer’s - Drug Target Review

Short peptides discovery could lead to new treatments for Alzheimer’s Drug Target Review

Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism - Science | AAAS

Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism Science | AAAS

China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use - GenomeWeb

China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use GenomeWeb

T-helper-1-cell cytokines drive cancer into senescence - Nature

T-helper-1-cell cytokines drive cancer into senescence Nature

Top 1Cell.Ai Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant